Log in

Relevant bibliographies by topics / Pharmaceutical Record / Journal articles

To see the other types of publications on this topic, follow the link: Pharmaceutical Record.

Journal articles on the topic 'Pharmaceutical Record'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pharmaceutical Record.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lopez-Cuadrado, Jose Luis, Israel Gonzalez-Carrasco, Jesus Leonardo Lopez-Hernandez, Paloma Martinez-Fernandez, and Jose Luis Martinez-Fernandez. "Automatic Learning Framework for Pharmaceutical Record Matching." IEEE Access 8 (2020): 171754–70. http://dx.doi.org/10.1109/access.2020.3024558.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Brander, G. "The pharmaceutical industry and The Veterinary Record." Veterinary Record 123, no. 1 (1988): 20–23. http://dx.doi.org/10.1136/vr.123.1.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Stefanacci, Richard G., Scott Guerin, and Tim Van Aken. "The Electronic Health Record Foundation for Pharmaceutical Management." Population Health Management 21, no. 3 (2018): 170–71. http://dx.doi.org/10.1089/pop.2017.0103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sillup, George P., Ronald K. Klimberg, and David P. McSweeney. "Data-Driven Decision Making for New Drugs." International Journal of Business Intelligence Research 1, no. 2 (2010): 42–59. http://dx.doi.org/10.4018/jbir.2010040105.

Full text

Abstract:

Two courses, advanced decision-making and pharmaceutical marketing, were combined in a collaborative process to mimic how the pharmaceutical industry determines the potential of new drugs. Integrated student teams worked together to complete semester-long projects and taught each other their respective knowledge areas—marketing and statistics. Real-world data for medical and pharmacy claims payments were “cleaned” and mined by students to analyze usage and cost patterns for anti-hypertensive and anti-hypercholesterolemia drugs currently on the market. Analyses included merging the medical and

APA, Harvard, Vancouver, ISO, and other styles

5

Jurado, Camille, Violaine Calmels, Emilie Lobinet, et al. "The Electronic Pharmaceutical Record: A new method for medication reconciliation." Journal of Evaluation in Clinical Practice 24, no. 4 (2018): 681–87. http://dx.doi.org/10.1111/jep.12942.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Vijayakumar, Thangavel Mahalingam. "SOAP progress notes: A systematic approach to record pharmaceutical care interventions." Current Medicine Research and Practice 6, no. 3 (2016): 129–30. http://dx.doi.org/10.1016/j.cmrp.2016.05.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Vezertzis, Konstantinos, George I. Lambrou, and Dimitrios Koutsouris. "Development of Patient Databases for Endocrinological Clinical and Pharmaceutical Trials: A Survey." Reviews on Recent Clinical Trials 15, no. 1 (2020): 5–21. http://dx.doi.org/10.2174/1574887114666191118122714.

Full text

Abstract:

Background: According to European legislation, a clinical trial is a research involving patients, which also includes a research end-product. The main objective of the clinical trial is to prove that the research product, i.e. a proposed medication or treatment, is effective and safe for patients. The implementation, development, and operation of a patient database, which will function as a matrix of samples with the appropriate parameterization, may provide appropriate tools to generate samples for clinical trials. Aim: The aim of the present work is to review the literature with respect to t

APA, Harvard, Vancouver, ISO, and other styles

8

Wang, Lidong, and Cheryl Ann Alexander. "Big Data Analytics for Medication Management in Diabetes Mellitus." International Journal of Studies in Nursing 1, no. 1 (2016): 42. http://dx.doi.org/10.20849/ijsn.v1i1.99.

Full text

Abstract:

Medication development plays a prominent role in the fight against chronic illness such as hypertension, diabetes mellitus, asthma, etc. Without proper testing and methods for management of drug data, the disease management would fail. Providers rely on pharmaceutical companies to provide research data in widespread formats and pharmaceutical companies rely on hospitals for electronic medical record data (EHR) and for pharmacy refill records from insurance companies. Big Data Analytics (BDA) provides an excellent basis to examine and manage terabytes of data that comprises drug data and can ma

APA, Harvard, Vancouver, ISO, and other styles

9

Fellous, Lesly, Benjamin Davido, Celine Leplay, Pénélope Randuineau, and Frédérique Bouchand. "Electronic Pharmaceutical Record: A tool to avoid medication errors at hospital admission." La Presse Médicale 48, no. 9 (2019): 999–1000. http://dx.doi.org/10.1016/j.lpm.2019.08.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bingham, Judith M., and Michael J. Dooley. "EXTRA-EXtravasation Treatment Record dAtabase: A Database to Record and Review Cytotoxic Drug Extravasation Events." Australian Journal of Hospital Pharmacy 28, no. 2 (1998): 89–93. http://dx.doi.org/10.1002/jppr199828289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Spinks, Jean M., and Jeff R. J. Richardson. "Paying the right price for pharmaceuticals: a case study of why the comparator matters." Australian Health Review 35, no. 3 (2011): 267. http://dx.doi.org/10.1071/ah10930.

Full text

Abstract:

This article considers the pricing policy for pharmaceuticals in Australia, which is widely seen as having achieved low drug prices. However, compared to New Zealand, the evidence implies that Australia might have improved its performance significantly if it had proactively sought market best pricing. The Australian record suggests that the information sought by authorities may not be sufficient for optimal pricing and that the economic evaluation of pharmaceuticals may be neither necessary nor sufficient for achieving this goal. What is known about the topic? Pharmaceutical expenditures vary

APA, Harvard, Vancouver, ISO, and other styles

12

Dupont, S., M. Coussemacq, J. Mareville, et al. "CPC-101 Pharmaceutical Intervention in the Patient Record: Towards Harmonisation of Our Practise." European Journal of Hospital Pharmacy 20, Suppl 1 (2013): A201.2—A201. http://dx.doi.org/10.1136/ejhpharm-2013-000276.558.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Arnold, Denis G., and James L. Oakley. "Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials." Journal of Health Politics, Policy and Law 44, no. 5 (2019): 765–87. http://dx.doi.org/10.1215/03616878-7611647.

Full text

Abstract:

Abstract Context: Spending on direct-to-consumer advertising (DTCA) for prescription pharmaceuticals has risen to record levels, five times as much as in 1996 in inflation-adjusted dollars. Major health care provider organizations have called for additional regulation of DTCA. These organizations argue that the negative impact of such advertising outweighs the informational value claimed by the pharmaceutical industry. The industry maintains that further restrictions on DTCA are not warranted because it is successfully self-regulating via “guiding principles” for DTCA as certified by firm exec

APA, Harvard, Vancouver, ISO, and other styles

14

Vicente, Kim J. "It Tools Must Fit User Needs to Improve Patient Safety Record." Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 137, no. 3 (2004): 33–35. http://dx.doi.org/10.1177/171516350413700302.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Salom, Caroline L., Lucinda A. Burns, and Rosa Alati. "Misuse of pharmaceuticals by regular psychostimulant users is linked to mental health problems." Salud mental 40, no. 6 (2017): 265–70. http://dx.doi.org/10.17711/sm.0185-3325.2017.034.

Full text

Abstract:

Introduction. Misuse of pharmaceutical drugs, particularly by young people, is an issue of rising concern. Poly-substance use is common among regular psychostimulant users (RPU), and mental health problems are associated with pharmaceutical misuse, but RPU do not generally acknowledge their use as problematic. Objective. To examine links between mental health and misuse of non-prescription pharmaceuticals in a group of regular users of illicit psychostimulants. Method. Face to face structured interviews were conducted in April 2015 with 763 regular users of illicit psychostimulants as part of

APA, Harvard, Vancouver, ISO, and other styles

16

REEPMEYER, GERRIT, OLIVER GASSMANN, and FRAUKE RÜTHER. "OUT-LICENSING IN MARKETS WITH ASYMMETRIC INFORMATION: THE CASE OF THE PHARMACEUTICAL INDUSTRY." International Journal of Innovation Management 15, no. 04 (2011): 755–95. http://dx.doi.org/10.1142/s1363919611003313.

Full text

Abstract:

Few large pharmaceutical companies have recently discovered out-licensing of terminated R&D results as a way to recoup some of the significant investments made in R&D and to improve R&D productivity. Our empirical investigation reveals that the licensing partners are preferably young, small and highly specialized companies. This reverses the traditional logic of out-licensing. While out-licensing is usually done because of downstream concerns, our analysis shows that the company which owns the necessary assets for further development (the large pharmaceutical company) sells the lic

APA, Harvard, Vancouver, ISO, and other styles

17

Lubarsky, David A., Iain C. Sanderson, William C. Gilbert, et al. "Using an Anesthesia Information Management System as a Cost Containment Tool." Anesthesiology 86, no. 5 (1997): 1161–69. http://dx.doi.org/10.1097/00000542-199705000-00020.

Full text

Abstract:

Background Medical informatics provide a new way to evaluate the practice of medicine. Anesthesia automated record keepers have introduced anesthesiologists to computerized medical records. To derive useful information from the stored data requires programming that is not currently commercially available. The authors describe how they custom-programmed an automated record keeper's database to perform cost calculations, how they validated the programming, and how they used the data in a successful pharmaceutical cost-containment program. Methods The Arkive (San Diego, CA) automated record keepe

APA, Harvard, Vancouver, ISO, and other styles

18

Bell, Jill A., Aaron Galaznik, Eileen Farrelly, et al. "Treatment Patterns and Outcomes Among Patients with Higher-Risk Myelodysplastic Syndromes Treated in a Real-World Setting: Electronic Medical Record-Based Data." Blood 128, no. 22 (2016): 5540. http://dx.doi.org/10.1182/blood.v128.22.5540.5540.

Full text

Abstract:

Abstract Introduction: Myelodysplastic syndromes (MDS) are a heterogeneous group of disorders resulting in ineffective hematopoiesis primarily affecting older adults; median age of diagnosis is >70 years. Treatment decisions in MDS are largely based on a prognostic scoring system that has been incorporated into some drug labeling (NCCN 2016). The use of hypomethylating agents (HMAs) in patients with higher-risk (HR) MDS is supported by consensus guidelines, thus the purpose of this study was to examine factors influencing prescribing patterns in this subset of patients. Methods: This was a

APA, Harvard, Vancouver, ISO, and other styles

19

KIMURA, Takeshi. "The Skill of Pharmacist's Record and How to Make Use It." YAKUGAKU ZASSHI 127, no. 2 (2007): 245–56. http://dx.doi.org/10.1248/yakushi.127.245.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Tiwari, Rai, Kumar, Parigger, and Rai. "Atomic and Molecular Laser-Induced Breakdown Spectroscopy of Selected Pharmaceuticals." Atoms 7, no. 3 (2019): 71. http://dx.doi.org/10.3390/atoms7030071.

Full text

Abstract:

Laser-induced breakdown spectroscopy (LIBS) of pharmaceutical drugs that contain paracetamol was investigated in air and argon atmospheres. The characteristic neutral and ionic spectral lines of various elements and molecular signatures of CN violet and C2 Swan band systems were observed. The relative hardness of all drug samples was measured as well. Principal component analysis, a multivariate method, was applied in the data analysis for demarcation purposes of the drug samples. The CN violet and C2 Swan spectral radiances were investigated for evaluation of a possible correlation of the che

APA, Harvard, Vancouver, ISO, and other styles

21

Nauli, Sukarno Bahat. "Analisa Perancangan Sistem Persediaan Bahan Baku Pada Perusahaan Farmasi." Jurnal Ilmiah FIFO 11, no. 2 (2019): 198. http://dx.doi.org/10.22441/fifo.2019.v11i2.009.

Full text

Abstract:

The development of technology in the field of information encourages each agency or company to keep abreast of its development, especially with regard to the development of information technology that has to do with the activities of the company. Pharmaceutical companies which produce drugs to provide goods for pharmacies and hospitals are very important to record the availability of drugs that are still feasible and drugs that have expired. So that the drug supply can be maintained and can be distributed with the needs of the drug properly. This study aims to design a Raw Material Inventory I

APA, Harvard, Vancouver, ISO, and other styles

22

Rervyatskyy, I. Yu. "A relational database with pharmaceutical information: problems of creation and primary filling for provision of a qualitative statistical processing." Farmatsevtychnyi zhurnal, no. 4 (September 10, 2019): 23–31. http://dx.doi.org/10.32352/0367-3057.4.19.03.

Full text

Abstract:

The disclosure of pharmaceutical information is not intended to provide the possibility of further automated processing of the data provided by independent experts, and, accordingly, the choice of the methods of presentation is aimed to optimize visual perception by users. The aim of the work was to analyze in the internet-sources the availability of information in the appropriate format for automatic filling of the relational database. The subjects of the study were: ATC: ICD-10 (International Classification of Diseases); content of EF 9.8; classification of dosage forms by the Ministry

APA, Harvard, Vancouver, ISO, and other styles

23

Reddy, D. Samba, and Savitha Reddy. "The Novel Drugs of 2015 – An Extraordinary Growth of Innovative Pharmaceuticals." International Journal of Pharmaceutical Sciences and Nanotechnology 9, no. 4 (2016): 3331–36. http://dx.doi.org/10.37285/ijpsn.2016.9.4.1.

Full text

Abstract:

The FDA has approved 45 new drugs in 2015, a record approval in two decades, indicating another year of excellent innovation and productivity. There are many regulatory pathways at the FDA for the approval of novel drugs. Sixteen drugs (36%) were First-in-Class with a new or unique mechanism of action for treating a disease. About 29% of the new drugs are biologics. Moreover, 21 of 45 (47%) are orphan drugs for the treatment of rare diseases. The FDA approved many new drugs to treat various forms of cancer, urinary tract infections, chronic hepatitis C, cystic fibrosis, irritable bowel syndrom

APA, Harvard, Vancouver, ISO, and other styles

24

Borba, Helena Hiemisch Lobo, and Denise Maria Woranovicz Carvalho. "Consumer behavior towards pharmaceutical services: a scoping review." International Journal for Innovation Education and Research 8, no. 8 (2020): 326–40. http://dx.doi.org/10.31686/ijier.vol8.iss8.2523.

Full text

Abstract:

The present study aimed to map the evidence on consumer’s behavior towards pharmaceutical services. A scoping review based on the PCC (Population, Concept, and Context) mnemonic was conducted in Pubmed, Scopus and Web of Science. Population included consumers of pharmaceutical services, the concept referred to marketing/consumer behavior and the context to pharmaceutical services. Electronic searches were held on December 2019. Studies published in non-roman characters were excluded. A qualitative synthesis of the data extracted from included studies (i.e. author, country, study design, aims,

APA, Harvard, Vancouver, ISO, and other styles

25

Grodzinski, Piotr. "NCI Centers of Cancer Nanotechnology Excellence (CCNEs) – A full story to set the record straight." Journal of Controlled Release 309 (September 2019): 341–42. http://dx.doi.org/10.1016/j.jconrel.2019.08.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Usir, Ezlina, Pei Lin Lua, and Abu Bakar Abdul Majeed. "Prevalence and Usage of Printed and Electronic Drug References and Patient Medication Records in Community Pharmacies in Malaysia." Journal of Pharmacy Practice 25, no. 3 (2012): 374–80. http://dx.doi.org/10.1177/0897190012442218.

Full text

Abstract:

This study aimed to determine the availability and usage of printed and electronic references and Patient Medication Record in community pharmacy. It was conducted for over 3 months from 15 January to 30 April 2007. Ninety-three pharmacies participated. Structured questionnaires were mailed to community pharmacies. Six weeks later a reminder was sent to all non responders, who were given another six weeks to return the completed questionnaire. Outcomes were analyzed using descriptive statistics and chi-square test of independence. Almost all the pharmacies (96.8%) have at least Monthly Index o

APA, Harvard, Vancouver, ISO, and other styles

27

Roos, Leslie L., Sumit Gupta, Ruth-Ann Soodeen, and Laurel Jebamani. "Data Quality in an Information-Rich Environment: Canada as an Example." Canadian Journal on Aging / La Revue canadienne du vieillissement 24, S1 (2005): 153–70. http://dx.doi.org/10.1353/cja.2005.0055.

Full text

Abstract:

ABSTRACTThis review evaluates the quality of available administrative data in the Canadian provinces, emphasizing the information needed to create integrated systems. We explicitly compare approaches to quality measurement, indicating where record linkage can and cannot substitute for more expensive record re-abstraction. Forty-nine original studies evaluating Canadian administrative data (registries, hospital abstracts, physician claims, and prescription drugs) are summarized in a structured manner. Registries, hospital abstracts, and physician files appear to be generally of satisfactory qua

APA, Harvard, Vancouver, ISO, and other styles

28

Langley, Paul, and Robert E. Martin. "Blockchains, Property Rights and Health Technology Assessment in the Pharmaceutical and Device(s) Industries." INNOVATIONS in pharmacy 9, no. 4 (2018): 1. http://dx.doi.org/10.24926/iip.v9i4.1444.

Full text

Abstract:

Ongoing concerns with the security of health information, both from the perspective of the individual patient as well as health systems has led to increased attention being given to the potential role of blockchain technology in the secure storage of health information through encryption, the integration of diverse health record systems and the vesting of property and access rights to health data in the patient. While the security offered by blockchain technology has long been recognized in the finance sector with the emergence of a range of cryptocurrencies as a medium of exchange and store o

APA, Harvard, Vancouver, ISO, and other styles

29

Reddy, D. Samba. "The Novel Drugs of 2014 –Record Approvals for Niche Markets." International Journal of Pharmaceutical Sciences and Nanotechnology 8, no. 3 (2015): 2889–93. http://dx.doi.org/10.37285/ijpsn.2015.8.3.1.

Full text

Abstract:

In 2014, 41 new drugs were approved by the FDA, the highest approval in two decades. This number was 52% higher than the 27 approvals in 2013, indicating another year of excellent innovation and productivity. Seventeen drugs (41%) were First-in-Class with a new or unique mechanism of action for treating a disease. Moreover, 17 of 41 (41%) of these novel drugs were for the treatment of rare diseases, a testament to continued focus or shift to niche diseases. The U.S. FDA is the leading authority for drug approvals worldwide. Many schemes and tracks at the FDA have led to accelerated approval of

APA, Harvard, Vancouver, ISO, and other styles

30

Tfaili, Sana, Cyril Gobinet, Jean-François Angiboust, Michel Manfait, and Olivier Piot. "Raman Microimaging Using a Novel Multifiber-Based Device: A Feasibility Study on Pharmaceutical Tablets." International Journal of Spectroscopy 2012 (April 22, 2012): 1–5. http://dx.doi.org/10.1155/2012/959235.

Full text

Abstract:

Raman microimaging is a potential analytical technique in health field and presents many possible pharmaceutical applications. In this study, we tested a micrometer spatial resolution probe coupled to a portable Raman imager via an indexed multifiber bundle. At the level of the probe, the fibers were arranged in a circular geometry in order to fit to the pupil of an objective. The imaging potential of this Raman system was assessed on pharmaceutical-like pellets. We showed that this setup permits to record, nearly in real time, Raman images with a micrometer resolution. The collected images re

APA, Harvard, Vancouver, ISO, and other styles

31

Steckler, Taylor. "Telepharmacy." Journal of Pharmacy Technology 32, no. 6 (2016): 227–29. http://dx.doi.org/10.1177/8755122516670415.

Full text

Abstract:

Telepharmacy involves pharmacist provision of clinical services at a distance and often includes electronic health record integration, audio-video connections, and increased patient access to pharmaceutical care. With the rapid expansion of this field comes critical questions that need to be answered by forward-thinking people in the profession. These issues include centralized checking workflows, potential reductions in patient counseling, and increased technician independence and responsibilities. If these points can be addressed with the needs of patients at the forefront, telepharmacy is p

APA, Harvard, Vancouver, ISO, and other styles

32

Lager, Stephanie, Betsy White, Megan Baumann, Randall E. Mitchem, Ronna Jackson, and Nicola Black. "Incidence of Cross-Sensitivity with Carbapenems in Documented Penicillin-Allergic Patients." Journal of Pharmacy Technology 25, no. 3 (2009): 159–63. http://dx.doi.org/10.1177/875512250902500303.

Full text

Abstract:

Background: When carbapenems were first introduced, it was recommended to use them cautiously in patients with a penicillin allergy due to an approximately 50% potential risk of cross-sensitivity in these patients. Carbapenems have a broad spectrum of coverage and may be necessary for treatment of acutely ill patients; however, clinicians may avoid the use of carbapenems in patients with a documented penicillin allergy. Objective: To further define the risk of cross-sensitivity to carbapenems in patients with a penicillin allergy that has been documented in the electronic medical record or has

APA, Harvard, Vancouver, ISO, and other styles

33

Ceska, Tom, Chun-Wa Chung, Rob Cooke, Chris Phillips, and Pamela A. Williams. "Cryo-EM in drug discovery." Biochemical Society Transactions 47, no. 1 (2019): 281–93. http://dx.doi.org/10.1042/bst20180267.

Full text

Abstract:

Abstract The impact of structural biology on drug discovery is well documented, and the workhorse technique for the past 30 years or so has been X-ray crystallography. With the advent of several technological improvements, including direct electron detectors, automation, better microscope vacuums and lenses, phase plates and improvements in computing power enabled by GPUs, it is now possible to record and analyse images of protein structures containing high-resolution information. This review, from a pharmaceutical perspective, highlights some of the most relevant and interesting protein struc

APA, Harvard, Vancouver, ISO, and other styles

34

Kirwin, Jennifer L., Margarita V. DiVall, Christina Guerra, and Todd Brown. "A Simulated Hospital Pharmacy Module Using an Electronic Medical Record in a Pharmaceutical Care Skills Laboratory Course." American Journal of Pharmaceutical Education 77, no. 3 (2013): 62. http://dx.doi.org/10.5688/ajpe77362.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

KUANG, LiPing, YingYun CAI, and Jing LI. "The contents and clinical significance of the first disease course record in the pharmaceutical history for trainees." Pharmaceutical Care and Research 11, no. 2 (2011): 119–22. http://dx.doi.org/10.5428/pcar20110214.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Staynova, Radiana, Yana Gvozdeva, Lily Peikova, and Anna Mihaylova. "Bulgarian community pharmacists’ attitudes and barriers towards pharmaceutical care provision for pregnant women." Pharmacia 68, no. 3 (2021): 511–16. http://dx.doi.org/10.3897/pharmacia.68.e68651.

Full text

Abstract:

The aim of this study was to assess the attitudes and perceived barriers towards pharmaceutical care provision for pregnant women in Bulgarian community pharmacies. A cross-sectional web-based study was carried out among community pharmacists in Plovdiv region, Bulgaria. The survey instrument was a self-administered questionnaire including 18 statements based on a five-point Likert scale. Descriptive statistics were applied to respondents’ characteristics and opinion regarding attitudes and barriers towards pharmaceutical care provision for pregnant women. A total of 122 community pharmacists

APA, Harvard, Vancouver, ISO, and other styles

37

Jakovljevic, Mihajlo B. "Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market." Farmeconomia. Health economics and therapeutic pathways 15, no. 1 (2014): 27–32. http://dx.doi.org/10.7175/fe.v15i1.909.

Full text

Abstract:

Monoclonal antibodies applied in clinical oncology present a therapeutic promise for many patients with cancer. Nevertheless these expensive protocols are associated with extremely high acquisition and administration costs. The issue of societal affordability of such treatment options is particularly at stake among middle income European economies. Medicines Agency of Serbia issues regular annual reports on public expenditure on pharmaceuticals since 2004. According to these official data total public expenditure on drugs doubled from 2004-2012 (from € 339,279,304 to € 742,013,976). During the

APA, Harvard, Vancouver, ISO, and other styles

38

Ritonga, Irfan, and Chairiandi Siregar. "Characteristics of Patients with Pelvis injury in General Hospital of Haji Adam Malik Medan." International Journal of PharmTech Research 13, no. 2 (2020): 103–9. http://dx.doi.org/10.20902/ijptr.2019.130213.

Full text

Abstract:

Objective- Fractures and injuries to the pelvic ringmay be associated with severe trauma and other associated injuries. This study aims to determine the characteristics of patients with pelvic injury in Adam Malik Haji General Hospital Medan. Material and Method-The type of research conducted is a retrospective descriptive research method. This study was conducted in Medan Haji Adam Malik Hospital based on medical records of traumatic pelvic injury patients during the period of January 2016 - December 2017. The data used is secondary data taken from the records in the patient's medical record.

APA, Harvard, Vancouver, ISO, and other styles

39

Uitvlugt, Elien B., Bart J. F. van den Bemt, Wai Lung Chung, Jaap Dik, Patricia M. L. A. van den Bemt, and Fatma Karapinar-Çarkit. "Validity of a nationwide medication record system in the Netherlands." International Journal of Clinical Pharmacy 41, no. 3 (2019): 687–90. http://dx.doi.org/10.1007/s11096-019-00839-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Barnett, David, and Rod Taylor. "INTRODUCTION." International Journal of Technology Assessment in Health Care 18, no. 2 (2002): 159–60. http://dx.doi.org/10.1017/s0266462302000156.

Full text

Abstract:

This special section is the written record of the second National Institute for Clinical Excellence (NICE) conference, which drew together experts in the fields of health technology assessment (HTA) from around the world. It includes a significant perspective from the pharmaceutical industry, whose partnership with the manufacturers of technologies (pharmaceuticals, devices, etc.) is of paramount importance to the successful future of the input of HTA into healthcare delivery. The importance of HTA as the basis of clinical decision making has never been more apparent. All clinicians are aware

APA, Harvard, Vancouver, ISO, and other styles

41

Center, John Hancock. "Confidentiality of Patient Health Information a Position Statement of the American Medical Record Association." Clinical Research Practices and Drug Regulatory Affairs 3, no. 3 (1985): 369–99. http://dx.doi.org/10.3109/10601338509051229.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bisschoff, Christo A., and Heinrich C. Barnard. "A Model to Measure the Service Quality of Pharmaceutical Wholesalers." Journal of Economics and Behavioral Studies 11, no. 3(J) (2019): 23–38. http://dx.doi.org/10.22610/jebs.v11i3(j).2866.

Full text

Abstract:

The study constituters a model to measure the service quality of pharmaceutical wholesalers in South Africa. Several pharmaceutical wholesalers distribute medical supplies throughout South Africa in a very regulated and competitive market where high service quality levels are anticipated. In this price-undifferentiated market, service quality can have a significant impact on the competitiveness of a pharmaceutical wholesaler. As a result, the primary objective was to develop a model to measure the service quality levels of large pharmaceutical wholesalers. The literature study compiled an indu

APA, Harvard, Vancouver, ISO, and other styles

43

Sapienza, Alice M. "Setting the record straight: The office of technology assessment report?pharmaceutical R&D costs, risks, and rewards." Drug Development Research 30, no. 2 (1993): 56–61. http://dx.doi.org/10.1002/ddr.430300203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Thiebault, Thomas, Léo Chassiot, Laëtitia Fougère, et al. "Record of pharmaceutical products in river sediments: A powerful tool to assess the environmental impact of urban management?" Anthropocene 18 (June 2017): 47–56. http://dx.doi.org/10.1016/j.ancene.2017.05.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Caballero, ML, and S. Quirce. "Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review." Journal of Investigational Allergology and Clinical Immunology 30, no. 6 (2020): 400–408. http://dx.doi.org/10.18176/jiaci.0562.

Full text

Abstract:

The European Medicines Agency (EMA) defines excipients as the constituents of a pharmaceutical form apart from the active substance. Delayed hypersensitivity reactions (DHRs) caused by excipients contained in the formulation of medications have been described. However, there are no data on the prevalence of DHRs due to drug excipients. Clinical manifestations of allergy to excipients can range from skin disorders to life-threatening systemic reactions. The aim of this study was to perform a literature review on allergy to pharmaceutical excipients and to record the DHRs described with various

APA, Harvard, Vancouver, ISO, and other styles

46

Berger, Gilles. "Pharmaceutical patent landscape for cancer immunotherapy: an interview with Gilles Berger." Pharmaceutical Patent Analyst 8, no. 5 (2019): 163–64. http://dx.doi.org/10.4155/ppa-2019-0021.

Full text

Abstract:

Dr Gilles Berger is a chemist and pharmacist with broad interest in organic and theoretical chemistry, drug discovery and design, biomedical sciences and oncology. He has worked as a Research Fellow in Brussels, Paris, Montreal and at MIT in Boston, where he has gathered hands-on experience at the interface of drug design, nanotechnologies, biology and human disease. He has been involved in project management and mentoring and has in depth experience in collaborative and multi-disciplinary projects, with a proven track record of publications in various fields, in collaboration with research gr

APA, Harvard, Vancouver, ISO, and other styles

47

Guénette, Line, and Caroline Sirois. "Pharmacy Record Registration of Acetyl Salicylic Acid (ASA) Prescriptions in Quebec." Journal of Pharmacy & Pharmaceutical Sciences 15, no. 2 (2012): 252. http://dx.doi.org/10.18433/j3d88g.

Full text

Abstract:

Purpose: To determine the extent of which acetyl salicylic acid (ASA) use is included in patients’ pharmacy records. Methods: During an in-home interview, people aged ≥65 years were asked to report all of the medications they had used at least once, including over-the-counter drugs, during the preceding month. Researchers recorded information on the drug name, reason for its use, and whether a physician prescribed it. From the pharmacy records, the drug names, prescription fill dates, quantities supplied, and the numbers of days’ supply were recorded. The level of agreement for ASA use across

APA, Harvard, Vancouver, ISO, and other styles

48

Rumambi, Frendy Rocky, Salahudin Robo, and Citra Amalia. "Identifikasi Dampak Penggunaan Sistem Informasi Rumah Sakit (SIRS) Terhadap Pelayanan Kesehatan Menggunakan Hot-Fit Model 2006." JURNAL MEDIA INFORMATIKA BUDIDARMA 4, no. 1 (2020): 216. http://dx.doi.org/10.30865/mib.v4i1.1973.

Full text

Abstract:

Hospital Information System (SIRS) is an integrated information system that aims to handle all hospital management processes, ranging from diagnostic services, medical data measures, medical records, pharmaceuticals, pharmaceutical warehouses, billing, personnel databases, payroll, and accounting to the control management. Based on Indonesian Constitution No. 44 Article 52 year 2009, paragraph 1 states that "Indonesian hospitals are required to record and report all activities that occur within a hospital". On the Indonesia ministry regulation, PERMENKES No. 1171 year of 2011, Article 1 paragr

APA, Harvard, Vancouver, ISO, and other styles

49

Tsourounis, C., S. Sohlberg, and A. M. Pollock. "Characterizing the significance of pharmacist interventions within an electronic medical record at a large academic medical center." Research in Social and Administrative Pharmacy 12, no. 4 (2016): e8. http://dx.doi.org/10.1016/j.sapharm.2016.05.021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Rubio, Brent K., Rob W. M. van Soest, and Phillip Crews. "Extending the Record of Meroditerpenes fromCacospongiaMarine Sponges." Journal of Natural Products 70, no. 4 (2007): 628–31. http://dx.doi.org/10.1021/np060633c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!